Plain-English translation of NCT05949580 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a digital care platform designed to help people with relapsing-remitting multiple sclerosis (RRMS) work more closely with their doctors. The platform has two main parts: an artificial intelligence tool that analyzes MRI brain scans to spot subtle disease changes, and a mobile app where you log your symptoms, medications, and health information that your care team can review. Researchers want to see whether these digital tools make it easier for patients and doctors to communicate and manage the disease together.
Multiple sclerosis progresses differently in each person, and sometimes important brain changes happen without obvious symptoms. This study exists to learn whether sharing real-time health data through digital tools and using AI to analyze brain scans helps doctors catch changes earlier and provide better, more personalized care.
You would use the icompanion patient app on your smartphone to regularly log your health information, symptoms, and medications, and fill out health questionnaires. Your doctors would have access to this data, along with your MRI images and an AI analysis of your brain scans, through a secure portal. Throughout the study, both you and your care team would complete questionnaires to help researchers understand whether this digital approach improves how well MS is managed and makes your care experience better.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
United States
Germany